carbidopa,Levodopa
NeuroDerm
['carbidopa']
topline results of the boundless trial of continuous sq levodopa infusion nd0612 in #pwp with motor fluctuations: nd0612 increased on time without dyskinesia by 1.7 h vs. ir-ld/cd and met 1st 4 hierarchical secondary endpoints, including updrs-ii &amp; pgic. #aanam 
Professor of #neurology @uofcincy. Walking the talk: there is no #Parkinsons but people with Parkinson's. Author, #BrainFables.